Table 10
Reasons invoked to contract out bioproduct related activities, Canada, 2009

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.

Symbols Next Previous

Reasons invoked to contract out bioproduct related activities, Canada, 2009


Table summary
This table displays the results of reasons invoked to contract out bioproduct related activities degree of importance and low, calculated using low, medium, high, not applicable and percent units of measure (appearing as column headers).

  Degree of importance
Low Medium High Not applicable
  percent
Access outside scientific expertise/knowledge 5.7A 5.3A 83.9A 5.1A
Activity area outside core competence
of firm
10.5A 20.7A 52.2B 16.6A
Faster completion of the work 21.4A 28.2A 37.4A 13.0A
Lower risks to the firm 34.3B 30.0A 18.1A 17.6A
Increase physical capacity (infrastructure,
equipment, etc.)
24.0A 23.3A 34.5B 18.2A
Access external R and D expertise 8.4A 30.7A 45.0B 15.9A
Access regulatory affairs expertise 33.3A 26.8A 23.0A 16.9A
Access production facilities 48.2B 8.1A 16.6A 27.1A
Other 0.0 1.1A 2.4A 96.5A
Note(s):
Due to rounding, components may not add to totals
Source(s):
Statistics Canada, Bioproducts production and development survey 2009.
Date modified: